Salota, Evangeline A.

HRN: 22-58-06  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/07/2023
CEFTRIAXONE 1G (VIAL)
02/07/2023
02/13/2023
IV
2gm
Q24
BPUD
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: No  No Infection 

Overall appropriateness: No  No Infection

Intervention



Type of Intervention done:

                    

           


Acceptance: